Clinical Trials
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
Tampa, FL & Butler, PA / Last Update Posted Aug 15, 2025 — This randomized, double-blinded, placebo-controlled trial evaluates the efficacy of biophoton therapy using biophoton generating devices in adults with Type 2 Diabetes. The study is currently recruiting at two locations in Florida and Pennsylvania.
For more details, please read the full study on ClinicalTrials.gov: NCT07124208.
Impact of Biophoton Therapy on Wellness and Healthy Aging in Adults 55+
New Castle, DE / Last Update Posted Oct 06, 2025 — This 12-month, open-label community study evaluates whether nightly use of biophoton generating devices can improve quality of life and reduce health risks in adults aged 55 and older. Participants use the non-invasive biophoton generating devices for at least 8 hours each night, while researchers track monthly changes in SF-36 quality-of-life and health-risk assessment scores to assess overall wellness benefits
For more details, please read the full study on ClinicalTrials.gov: NCT07124208.
Impact of Biophoton Therapy on Chronic Severe Arthritis Pain
Butler, PA / ClinicalTrials.gov / Last Update Posted April 07, 2025 — Aimed at easing chronic severe arthritis pain, this randomized, double-blinded clinical trial examines whether biophoton therapy can significantly reduce pain over a 12-week period. The study uses a variety of assessments, including visual analog scales, quality-of-life questionnaires, and inflammatory markers, to gather solid data on treatment effectiveness.
For more details, please read the full study on ClinicalTrials.gov: NCT06915012.
The Impact of Biophoton Therapy on Self-Grown Stem Cells (Stem Cells)
Butler, PA / ClinicalTrials.gov / Last Update Posted March 05, 2025 — In this double-blinded, placebo-controlled study, about 46 volunteers are being evaluated to see if biophoton therapy naturally increases self-grown stem cells. Participants use the treatment over a course of 2 weeks (with a placebo group extending to 4 weeks), while researchers track changes in stem cell counts, pain, and overall quality of life.
For more details, please read the full study on ClinicalTrials.gov: NCT06855459.
Impact of Biophoton Generator on Chronic-Stroke Patients' Recovery
Philadelphia, PA / ClinicalTrials.gov / Last Update Posted July 01, 2024 — This randomized, double-blinded, placebo-controlled trial investigates whether daily use of biophoton generating devices can help chronic stroke patients regain their independence. The study employs EEG tests and assessments of activities of daily living to objectively measure recovery.
For more details, please read the full study on ClinicalTrials.gov: NCT05898334.
Impact of Biophoton Therapy on Patients With Brain Disorders (Alzheimer)
Butler, PA / ClinicalTrials.gov / Last Update Posted November 30, 2023 — The First Institute of All Medicines is conducting a randomized, triple‐blinded, placebo-controlled study to confirm earlier findings that biophoton therapy is safe and effective for patients with brain disorders. About 80 patients with conditions such as Alzheimer’s, dementia, stroke, traumatic brain injury, and Parkinson’s disease are enrolled to assess improvements in cognitive and overall health.
For more details, please read the full study on ClinicalTrials.gov: NCT06147999.